471 related articles for article (PubMed ID: 27441500)
1. The cancer/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas.
Nettersheim D; Arndt I; Sharma R; Riesenberg S; Jostes S; Schneider S; Hölzel M; Kristiansen G; Schorle H
Br J Cancer; 2016 Aug; 115(4):454-64. PubMed ID: 27441500
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of preferentially expressed antigen in melanoma (PRAME) in testicular germ cell tumors - A comparative study with SOX17.
Zhou Y; Rothrock A; Murugan P; Li F; Bu L
Exp Mol Pathol; 2022 Jun; 126():104761. PubMed ID: 35390309
[TBL] [Abstract][Full Text] [Related]
3. The seminoma cell line TCam-2 is sensitive to HDAC inhibitor depsipeptide but tolerates various other chemotherapeutic drugs and loss of NANOG expression.
Nettersheim D; Gillis A; Biermann K; Looijenga LH; Schorle H
Genes Chromosomes Cancer; 2011 Dec; 50(12):1033-42. PubMed ID: 21987446
[TBL] [Abstract][Full Text] [Related]
4. Unique and redundant roles of SOX2 and SOX17 in regulating the germ cell tumor fate.
Jostes SV; Fellermeyer M; Arévalo L; Merges GE; Kristiansen G; Nettersheim D; Schorle H
Int J Cancer; 2020 Mar; 146(6):1592-1605. PubMed ID: 31583686
[TBL] [Abstract][Full Text] [Related]
5. SOX2 is essential for in vivo reprogramming of seminoma-like TCam-2 cells to an embryonal carcinoma-like fate.
Nettersheim D; Heimsoeth A; Jostes S; Schneider S; Fellermeyer M; Hofmann A; Schorle H
Oncotarget; 2016 Jul; 7(30):47095-47110. PubMed ID: 27283990
[TBL] [Abstract][Full Text] [Related]
6. Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance.
Wermann H; Stoop H; Gillis AJ; Honecker F; van Gurp RJ; Ammerpohl O; Richter J; Oosterhuis JW; Bokemeyer C; Looijenga LH
J Pathol; 2010 Aug; 221(4):433-42. PubMed ID: 20593487
[TBL] [Abstract][Full Text] [Related]
7. Chromosome X-encoded Cancer/Testis antigens are less frequently expressed in non-seminomatous germ cell tumors than in seminomas.
Chen YT; Cao D; Chiu R; Lee P
Cancer Immun; 2013; 13():10. PubMed ID: 23885216
[TBL] [Abstract][Full Text] [Related]
8. The plasticity of germ cell cancers and its dependence on the cellular microenvironment.
Nettersheim D; Schorle H
J Cell Mol Med; 2017 Aug; 21(8):1463-1467. PubMed ID: 28244655
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical Expression of Preferentially Expressed Antigen in Melanoma (PRAME) in the Uninvolved Background Testis, Germ Cell Neoplasia In Situ, and Germ Cell Tumors of the Testis.
Ricci C; Franceschini T; Giunchi F; Grillini M; Ambrosi F; Massari F; Mollica V; Colecchia M; Fiorentino M
Am J Clin Pathol; 2022 May; 157(5):644-648. PubMed ID: 34864837
[TBL] [Abstract][Full Text] [Related]
10. Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis.
Gillis AJ; Stoop H; Biermann K; van Gurp RJ; Swartzman E; Cribbes S; Ferlinz A; Shannon M; Oosterhuis JW; Looijenga LH
Int J Androl; 2011 Aug; 34(4 Pt 2):e160-74. PubMed ID: 21631526
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression and distribution of the OCT-4 transcription factor in seminomas.
Cheng CJ; Wu YC; Shu JA; Ling TY; Kuo HC; Wu JY; Chang EE; Chang SC; Huang YH
J Biomed Sci; 2007 Nov; 14(6):797-807. PubMed ID: 17682839
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor-beta expression in human testicular germ cell tumors.
Pais V; Leav I; Lau KM; Jiang Z; Ho SM
Clin Cancer Res; 2003 Oct; 9(12):4475-82. PubMed ID: 14555521
[TBL] [Abstract][Full Text] [Related]
13. Assessment of piRNA biogenesis and function in testicular germ cell tumors and their precursor germ cell neoplasia in situ.
Gainetdinov IV; Skvortsova YV; Kondratieva SA; Klimov A; Tryakin AA; Azhikina TL
BMC Cancer; 2018 Jan; 18(1):20. PubMed ID: 29301509
[TBL] [Abstract][Full Text] [Related]
14. TGF-β1, EGF and FGF4 synergistically induce differentiation of the seminoma cell line TCam-2 into a cell type resembling mixed non-seminoma.
Nettersheim D; Gillis AJ; Looijenga LH; Schorle H
Int J Androl; 2011 Aug; 34(4 Pt 2):e189-203. PubMed ID: 21649665
[TBL] [Abstract][Full Text] [Related]
15. An in vitro model demonstrates the potential of neoplastic human germ cells to influence the tumour microenvironment.
Klein B; Schuppe HC; Bergmann M; Hedger MP; Loveland BE; Loveland KL
Andrology; 2017 Jul; 5(4):763-770. PubMed ID: 28544640
[TBL] [Abstract][Full Text] [Related]
16. BMP Inhibition in Seminomas Initiates Acquisition of Pluripotency via NODAL Signaling Resulting in Reprogramming to an Embryonal Carcinoma.
Nettersheim D; Jostes S; Sharma R; Schneider S; Hofmann A; Ferreira HJ; Hoffmann P; Kristiansen G; Esteller MB; Schorle H
PLoS Genet; 2015 Jul; 11(7):e1005415. PubMed ID: 26226633
[TBL] [Abstract][Full Text] [Related]
17. SOX2 and PRAME in the "reprogramming" of seminoma cells.
Orsatti A; Sirolli M; Ambrosi F; Franceschini T; Giunchi F; Franchini E; Grillini M; Massari F; Mollica V; Bianchi FM; Colecchia M; Fiorentino M; Ricci C
Pathol Res Pract; 2022 Sep; 237():154044. PubMed ID: 35930824
[TBL] [Abstract][Full Text] [Related]
18. Novel germ cell markers characterize testicular seminoma and fetal testis.
Gashaw I; Dushaj O; Behr R; Biermann K; Brehm R; Rübben H; Grobholz R; Schmid KW; Bergmann M; Winterhager E
Mol Hum Reprod; 2007 Oct; 13(10):721-7. PubMed ID: 17785371
[TBL] [Abstract][Full Text] [Related]
19. Chromosome X-encoded cancer/testis antigens show distinctive expression patterns in developing gonads and in testicular seminoma.
Chen YT; Chiu R; Lee P; Beneck D; Jin B; Old LJ
Hum Reprod; 2011 Dec; 26(12):3232-43. PubMed ID: 22016418
[TBL] [Abstract][Full Text] [Related]
20. Expression patterns of cancer testis antigens in testicular germ cell tumors and adjacent testicular tissue.
Yuasa T; Okamoto K; Kawakami T; Mishina M; Ogawa O; Okada Y
J Urol; 2001 May; 165(5):1790-4. PubMed ID: 11342977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
